Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Global health R&D delivers forHawaii

Map
Hawaii
Select a new state
Select a State
Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois
Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana
Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island
South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

US government investment in global health R&D has delivered

$8.0 million
to Hawaii research institutions
100+ new jobs
for Hawaii
Hawaii

Neglected diseases in Hawaii

Chikungunya cases
Chikungunya cases
34
Dengue cases
Dengue cases
231
HIV diagnoses
HIV diagnoses
852
Malaria cases
Malaria cases
30
Tuberculosis cases
Tuberculosis cases
1093
West Nile cases
West Nile cases
1
Zika cases
Zika cases
17
Hawaii's top USG-funded global health R&D institutions

Hawaii's top USG-funded global health R&D institutions

University of Hawaii at Manoa
$7.6 million
University of Hawaii at Hilo
$429 thousand
Hawaii industry in global health R&D

Hawaii industry in global health R&D

Hawaii Biotech
Location(s): Honolulu

Hawaii's top areas of global health R&D by USG funding

48.9%
Malaria
5.4%
Tuberculosis
6.3%
Ebola/viral hemorrhagic fevers
38.5%
Neglected tropical diseases
Dengue
0.9%
Other
Non-allocable
Global health R&D at work in Hawaii
Global health R&D at work in Hawaii

Researchers at the University of Hawaii are studying the Zika virus to unlock new approaches and treatments to prevent the virus from being transmitted from pregnant mother to fetus. They want to understand how Zika is transmitted to the fetus and how infection can impair infants, causing developmental delays and physical disorders. They are also examining whether the timing of infection during pregnancy affects the damage it causes. Hawaii is particularly at risk for transmission of Zika due to its favorable climate and numerous visitors from all over the world, including from countries where Zika is widespread. Several cases of Zika have been reported in the state. Supported by the National Institutes of Health, the Zika virus research is important to the health and economy of Hawaii.

Download PDF
Map
Select a new state
Footnotes
  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: IAEA/Omar Yusuf
Close
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In